3 ms·
This may be somewhat difficult, however, given the prior art of Shulgin and others: https://en.wikipedia.org/wiki/TiHKAL https://en.wikipedia.org/wiki/TiHKAL. T
by jseliger 4y ago
This may be somewhat difficult, however, given the prior art of Shulgin and others: https://en.wikipedia.org/wiki/TiHKAL https://en.wikipedia.org/wiki/TiHKAL. TIHKAL and PIHKAL cover a lot of ground.
- CameronNemo 4y agoThe problem is not that we lack patent unencumbered medicine, the problem is that only patent encumbered medicine has the incentives behind it to fund studies into its safety, and the rest of the FDA process.